X Square Capital, LLC Aveo Pharmaceuticals, Inc. Transaction History

X Square Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.12 - $6.89 $43,776 - $58,909	-8,550 Reduced 8.48%	92,283 $570,000
Q2 2021 Aug 16, 2021	SELL	$6.21 - $7.45 $2,577 - $3,091	-415 Reduced 0.41%	100,833 $665,000
Q1 2021 May 13, 2021	BUY	$5.97 - $15.28 $151,017 - $386,522	25,296 Added 33.31%	101,248 $741,000
Q4 2020 Feb 12, 2021	BUY	$5.08 - $6.68 $385,836 - $507,359	75,952 New	75,952 $438,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on X Square Capital, LLC with notifications on news.